Danganan, Shine-shine .
HRN: 05-15-91 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/22/2025
CEFUROXIME 500MG (TAB)
01/22/2025
01/29/2025
ORAL
500 Mg/tab
BID
S/p NSD With RMLE And Repair
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes